Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-104,820
Closed -$2.07M 74
2023
Q2
$2.07M Sell
104,820
-20,233
-16% -$318K 0.17% 57
2023
Q1
$2.04M Buy
125,053
+74,531
+148% +$1.15M 0.14% 49
2022
Q4
$528K Buy
+50,522
New +$448K 0.05% 59
2021
Q4
Sell
-84,115
Closed -$6.35M 118
2021
Q3
$6.35M Buy
84,115
+79,522
+1,731% +$8.42M 0.44% 51
2021
Q2
$772K Hold
4,593
0.05% 83
2021
Q1
$805K Buy
4,593
+2,614
+132% +$527K 0.06% 77
2020
Q4
$405K Buy
1,979
+1,104
+126% +$205K 0.05% 55
2020
Q3
$171K Buy
+875
New +$211K 0.04% 49

Other funds holding GOCO

Eversept Partners's GOCO Position: Q3 2023 in Review

Eversept Partners sold out of GoHealth (GOCO) in Q3 2023, closing a stake of 104,820 shares — an estimated $2.07M sold.

Eversept Partners first reported a position in GOCO in Q3 2020 and held it in 8 quarters. The position peaked at $6.35M in Q3 2021. 44 funds tracked by Wall St. Rank hold GOCO as of Q3 2023.

  • Eversept Partners reported no remaining GoHealth position as of Q3 2023 after selling out during the quarter.
  • Eversept Partners sold 104,820 GoHealth shares in Q3 2023, an estimated $2.07M.
  • Eversept Partners first reported a position in GoHealth in Q3 2020 and held it in 8 quarters.
  • Eversept Partners's GoHealth position peaked at $6.35M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held GoHealth as of Q3 2023.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.